Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence-Driven Angiography-Based Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI

NCT07329699 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07329699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07329699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence-Driven Angiography-Based Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
March 18, 2026
Completion date
December 31, 2029
Enrollment
2,100 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, chronic coronary syndrome, coronary artery disease